Cannabis Bioscience International Holdings, Inc. (CBIH)
| Previous close | 0.0006 |
| Open | 0.0006 |
| Bid | 0.0007 x 0 |
| Ask | 0.0008 x 0 |
| Day's range | 0.0006 - 0.0009 |
| 52-week range | 0.0003 - 0.0018 |
| Volume | |
| Avg. volume | 6,843,366 |
| Market cap | 8.305M |
| Beta (5Y monthly) | -0.02 |
| PE ratio (TTM) | 0.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTCMKTS: CBIH), to fund the clinical data collection efforts of CBIH’s rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity. Through this strategic alliance, Vita Biotech will act as a financial subsidiary and catalyst for CBIH
- GlobeNewswire
Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer o
- GlobeNewswire
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH
HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA (Financial Industry Regulatory Authority, Inc.) has approved the corporate name change from “China Infrastructure Construction Corp.” to “Cannabis Bioscience International Holdings” as well as its ticker symbo
